Stem cell researcher Dr. Ann Kiessling announced today the discovery of cell characteristics that may
explain important differences between embryonic stem cells and adult stem cells. Scientists have for
years been frustrated in their efforts to grow the trillions of adult stem cells needed for therapies, which is
why embryonic stem cells seem promising--they can multiply endlessly and also develop into any cell in
Kiessling discovered that early human embryo cells express CLOCK, and other circadian genes, that
other human cells growing in laboratories did not. This was a surprise. Although scientists have recently
become aware that human tissues have a circadian oscillator that cycles every 24 hours, in phase with
the master circadian pacemaker in the brain that responds to light and dark, early embryos seemed too
small to function like a tissue.
Kiessling also discovered that the RB gene, a powerful cell blockade, was turned off in the early embryo
cells. This was also a surprise because RB is a well-studied blockade that prevents cells from multiplying
unless needed and stimulated by growth factors. The lack of RB in the early embryo cells, in combination
with the circadian oscillator, are unique characteristics that together enable independent, continuous cell
"These are exciting discoveries," stated Dr. Kiessling. "To understand the cell machinery needed for
independent, highly accurate cell multiplication, we need to understand early embryos, because they are
the true stem cells. CLOCK expression and RB silence may be key elements in continuous cell
duplication, and important to consider in the design of patient-specific stem cells capable of the
expansion needed for therapeutic quantities."
Developing conditions to inhibit RB and support the circadian oscillator may the combination long sought
by scientists to multiply adult stem cells to the trillions needed for therapies for diseases such as heart
failure, diabetes, Parkinson's disease, spinal cord injury, AIDS and cancer.
"These findings are also essential to our research to improve the efficiency of deriving stem cells from
unfertilized eggs, called parthenote stem cells. Parthenote stem cells do not have the ethical issues that
embryos have, and appear to be as robust in multiplication as embryonic stem cells. Women with serious
diseases, such as Huntington's Disease, spinal cord injury, and Chrone's disease, have volunteered to
donate their eggs for stem cell research and derivation, a procedure well worth undertaking when this
new knowledge can be implemented. Strategies to silence the RB gene will need to be carefully planned
to allow it to turn back on when the cells are differentiated to specific cell types, " Dr. Kiessling said.
This ground-breaking work was the result of a collaboration between Dr. Kiessling's team of scientists at
the Massachusetts based Bedford Research Foundation (BRF) with a team of clinician scientists at the
University of Athens in Greece. The work is the first of its kind and was possible through the use of
cutting-edge microarray technology. BRF scientists examined expression of 44,000 gene elements in
discarded early-stage (8 cells of development) human embryos.
Professor Dimitris Loutradis, the clinician scientist leading the Greek team, adds "This new understanding
of human embryos may, finally, help develop ways to determine which embryo is developing normally
and should be selected for transfer to patients undergoing assisted reproduction."
According to Professor Jose Cibelli of Michigan State University, "This is a seminal paper. I am sure we
will be referring back to it 10, 20 years from now."
Bedford Stem Cell
Research Foundation Headquarters
PO Box 1028
Bedford, MA 01730
260 Elm Street, Suite 106
Somerville, MA 02144